FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to cardiology, and concerns a method for assessing atherogenicity of apolipoprotein of B-containing lipoproteins. Proposed method consists in the fact that in the patients is analyzed subfractional distribution of low density lipoproteins. By original mathematical formula calculating the coefficient, reflecting ratio between atherogenic and physiologically active species. Invention can be used for assessing atherogenicity of apolipoprotein B-containing lipoproteins with the possibility of non-invasive detection of coronary artery injury.
EFFECT: method allows specifying the indications for performing coronarographic study.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTION AND STUDY OF ATHEROGENICITY OF IMMUNE COMPLEXES CONTAINING MULTIPLE MODIFIED LIPOPROTEINS | 2016 |
|
RU2632118C1 |
| METHOD FOR SEPARATION AND QUANTITATIVE DETERMINATION OF MULTIPLY MODIFIED LOW-DENSITY LIPOPROTEINS | 2015 |
|
RU2592238C1 |
| METHOD FOR ASSESSING PROGRESSION OF ATHEROGENICITY IN ISCHEMIC HEART DISEASE | 2013 |
|
RU2521322C1 |
| METHOD FOR SCREENING DIAGNOSIS OF CORONARY ATHEROSCLEROSIS USING NON-INVASIVE CA-BIOMARKER | 2021 |
|
RU2760539C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2013 |
|
RU2517054C1 |
| METHOD OF ANALYZING DISTURBANCE OF LIPOPROTEIN SPECTRUM OF BLOOD PLASMA | 0 |
|
SU1467516A1 |
| HYPOLIPIDEMIC PREPARATION "ATORVAGLYSIN" | 2008 |
|
RU2396079C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN LIPIDEMIA | 2011 |
|
RU2462718C1 |
| AGENT POSSESSING HYPOLIPIDEMIC ACTIVITY | 2020 |
|
RU2732503C1 |
| METHOD FOR DIAGNOSING ATHEROSCLEROSIS IN PNEUMONIA PATIENTS | 0 |
|
SU1668951A1 |
